Payment overview · 2025
General Payments
$568.76
5 reported records · 4 companies
Healthcare provider profile · identity verified
Kent Matthew Davis, MD
Allopathic & Osteopathic Physicians|Internal Medicine · TYLER, TX · NPI 1548259179
Verified facts
What the public records show
CMS Open Payments records show Kent Matthew Davis, MD received $568.76 in general payments during 2025 across 5 reported records.
Neurocrine BioSciences, Inc. accounted for 38.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
Janssen Pharmaceuticals, Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported INVEGA SUSTENNA as an associated drug or biological on 39068 records involving 11966 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Invega Sustenna by this doctor in 2024.
Janssen Pharmaceuticals, Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported XARELTO as an associated drug or biological on 28 records involving 28 distinct recipient NPIs. Public Medicare Part D data also shows 115 claims for Xarelto by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $220.81 | 38.8% | 2 | 2025 |
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $136.38 | 24.0% | 1 | 2025 |
| Janssen Pharmaceuticals, Inc | Unresolved — no canonical attribution shown | $125.00 | 22.0% | 1 | 2025 |
| ACADIA Pharmaceuticals Inc | Unresolved — no canonical attribution shown | $86.57 | 15.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $568.76 | 5 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $220.81 | 2 | 2025 |
Source payment records
|
|||||
| AUSTEDO XR Normalized: austedo xr |
Drug | Teva Pharmaceuticals USA, Inc. | $136.38 | 1 | 2025 |
Source payment records
|
|||||
| SPRAVATO Normalized: spravato |
Drug | Janssen Pharmaceuticals, Inc | $125.00 | 1 | 2025 |
Source payment records
|
|||||
| NUPLAZID Normalized: nuplazid |
Drug | ACADIA Pharmaceuticals Inc | $86.57 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Janssen Pharmaceuticals, Inc Exact reporting entity; no affiliate inference |
2025 | INVEGA SUSTENNA open payments reported associated product |
CMS Open Payments — General Payments 39068 supporting records · 11966 recipient NPIs · example record 1174223262 |
Invega Sustenna · 2024 Exact normalized brand match · 1 Part D row |
15 | suppressed by CMS |
| Janssen Pharmaceuticals, Inc Exact reporting entity; no affiliate inference |
2025 | XARELTO open payments reported associated product |
CMS Open Payments — General Payments 28 supporting records · 28 recipient NPIs · example record 1174296970 |
Xarelto · 2024 Exact normalized brand match · 1 Part D row |
115 | 15 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 863 | 171 |
| Levothyroxine Sodium | Levothyroxine Sodium | 755 | 88 |
| Eliquis | Apixaban | 751 | 90 |
| Furosemide | Furosemide | 736 | 101 |
| Potassium Chloride | Potassium Chloride | 577 | 117 |
| Amlodipine Besylate | Amlodipine Besylate | 519 | 107 |
| Pantoprazole Sodium | Pantoprazole Sodium | 508 | 86 |
| Gabapentin | Gabapentin | 463 | 86 |
| Donepezil Hcl | Donepezil Hcl | 292 | 46 |
| Clopidogrel | Clopidogrel Bisulfate | 278 | 57 |
| Lisinopril | Lisinopril | 265 | 57 |
| Sertraline Hcl | Sertraline Hcl | 253 | 37 |
| Metoprolol Tartrate | Metoprolol Tartrate | 242 | 66 |
| Carvedilol | Carvedilol | 241 | 58 |
| Memantine Hcl | Memantine Hcl | 241 | 38 |
| Tamsulosin Hcl | Tamsulosin Hcl | 240 | 51 |
| Trazodone Hcl | Trazodone Hcl | 218 | 36 |
| Metoprolol Succinate | Metoprolol Succinate | 194 | 48 |
| Metformin Hcl | Metformin Hcl | 185 | 43 |
| Escitalopram Oxalate | Escitalopram Oxalate | 174 | 27 |
| Tramadol Hcl | Tramadol Hcl | 172 | 44 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 168 | 35 |
| Famotidine | Famotidine | 165 | 30 |
| Levetiracetam | Levetiracetam | 165 | 24 |
| Losartan Potassium | Losartan Potassium | 165 | 36 |
| Ondansetron Hcl | Ondansetron Hcl | 163 | 60 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 152 | 32 |
| Buspirone Hcl | Buspirone Hcl | 149 | 26 |
| Divalproex Sodium | Divalproex Sodium | 149 | 20 |
| Simvastatin | Simvastatin | 142 | 19 |
| Montelukast Sodium | Montelukast Sodium | 137 | 25 |
| Lorazepam | Lorazepam | 136 | 30 |
| Omeprazole | Omeprazole | 129 | 35 |
| Mirtazapine | Mirtazapine | 120 | 35 |
| Hydralazine Hcl | Hydralazine Hcl | 119 | 24 |
| Myrbetriq | Mirabegron | 115 | suppressed |
| Xarelto | Rivaroxaban | 115 | 15 |
| Baclofen | Baclofen | 114 | 15 |
| Duloxetine Hcl | Duloxetine Hcl | 114 | 24 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 111 | 20 |
| Allopurinol | Allopurinol | 109 | 23 |
| Bumetanide | Bumetanide | 106 | 36 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 96 | 23 |
| Finasteride | Finasteride | 95 | 19 |
| Methocarbamol | Methocarbamol | 94 | 27 |
| Fluoxetine Hcl | Fluoxetine Hcl | 91 | 19 |
| Fluticasone Propionate | Fluticasone Propionate | 90 | 27 |
| Citalopram Hbr | Citalopram Hydrobromide | 88 | 15 |
| Pravastatin Sodium | Pravastatin Sodium | 87 | 21 |
| Clonazepam | Clonazepam | 83 | suppressed |
| Pregabalin | Pregabalin | 83 | 18 |
| Midodrine Hcl | Midodrine Hcl | 78 | 17 |
| Prednisone | Prednisone | 75 | 22 |
| Farxiga | Dapagliflozin Propanediol | 73 | 12 |
| Latanoprost | Latanoprost | 69 | 17 |
| Cephalexin | Cephalexin | 68 | 39 |
| Hydrochlorothiazide | Hydrochlorothiazide | 65 | 13 |
| Tizanidine Hcl | Tizanidine Hcl | 64 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 63 | 13 |
| Ropinirole Hcl | Ropinirole Hcl | 63 | 14 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 62 | 20 |
| Propranolol Hcl | Propranolol Hcl | 58 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 57 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 56 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 56 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 56 | 17 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 55 | 15 |
| Spironolactone | Spironolactone | 53 | 16 |
| Meloxicam | Meloxicam | 52 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 50 | 19 |
| Nystatin | Nystatin | 50 | 23 |
| Doxazosin Mesylate | Doxazosin Mesylate | 49 | suppressed |
| Lacosamide | Lacosamide | 49 | suppressed |
| Temazepam | Temazepam | 49 | suppressed |
| Entresto | Sacubitril/Valsartan | 48 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 46 | 36 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 46 | 14 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 46 | 32 |
| Sucralfate | Sucralfate | 46 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 43 | 16 |
| Jardiance | Empagliflozin | 42 | suppressed |
| Torsemide | Torsemide | 41 | 13 |
| Alprazolam | Alprazolam | 40 | suppressed |
| Digoxin | Digoxin | 40 | suppressed |
| Gemtesa | Vibegron | 40 | suppressed |
| Lansoprazole | Lansoprazole | 40 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 40 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 40 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 39 | suppressed |
| Glimepiride | Glimepiride | 39 | suppressed |
| Ezetimibe | Ezetimibe | 38 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 37 | 27 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 37 | suppressed |
| Topiramate | Topiramate | 36 | suppressed |
| Atenolol | Atenolol | 35 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 34 | suppressed |
| Tradjenta | Linagliptin | 34 | suppressed |
| Olanzapine | Olanzapine | 33 | suppressed |
| Risperidone | Risperidone | 33 | suppressed |
| Klayesta | Nystatin | 32 | 16 |
| Solifenacin Succinate | Solifenacin Succinate | 32 | suppressed |
| Zidovudine | Zidovudine | 32 | suppressed |
| Carbamazepine | Carbamazepine | 31 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 31 | 21 |
| Dicyclomine Hcl | Dicyclomine Hcl | 31 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 31 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 30 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 30 | suppressed |
| Lamivudine | Lamivudine | 30 | suppressed |
| Ondansetron Odt | Ondansetron | 30 | 15 |
| Carbamazepine Er | Carbamazepine | 29 | suppressed |
| Primidone | Primidone | 29 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 28 | 16 |
| Bupropion Xl | Bupropion Hcl | 28 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 28 | suppressed |
| Budesonide | Budesonide | 27 | suppressed |
| Levofloxacin | Levofloxacin | 27 | 16 |
| Lidocaine | Lidocaine | 27 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 27 | 27 |
| Fycompa | Perampanel | 26 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 26 | 12 |
| Aripiprazole | Aripiprazole | 25 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 25 | suppressed |
| Corlanor | Ivabradine Hcl | 25 | suppressed |
| Glipizide | Glipizide | 25 | suppressed |
| Creon | Lipase/Protease/Amylase | 24 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 24 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 24 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 24 | suppressed |
| Lactulose | Lactulose | 24 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 24 | suppressed |
| Tivicay | Dolutegravir Sodium | 24 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 23 | suppressed |
| Diazepam | Diazepam | 23 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 22 | suppressed |
| Novolog Flexpen | Insulin Aspart | 22 | suppressed |
| Zonisamide | Zonisamide | 22 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 21 | 16 |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 21 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 21 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 21 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 21 | suppressed |
| Methotrexate | Methotrexate Sodium | 20 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 19 | suppressed |
| Metolazone | Metolazone | 19 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 19 | 15 |
| Trulicity | Dulaglutide | 19 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 19 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 18 | suppressed |
| Cilostazol | Cilostazol | 18 | suppressed |
| Januvia | Sitagliptin Phosphate | 18 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 18 | suppressed |
| Brinzolamide | Brinzolamide | 17 | suppressed |
| Cefdinir | Cefdinir | 17 | 11 |
| Dapagliflozin | Dapagliflozin Propanediol | 17 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 17 | suppressed |
| Lovastatin | Lovastatin | 17 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 17 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 17 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 16 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 16 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Nitroglycerin | Nitroglycerin | 16 | 12 |
| Sotalol | Sotalol Hcl | 16 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 15 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 15 | 12 |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 15 | suppressed |
| Fluconazole | Fluconazole | 15 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 15 | suppressed |
| Tiotropium Bromide | Tiotropium Bromide | 15 | suppressed |
| Zenpep | Lipase/Protease/Amylase | 15 | suppressed |
| Anastrozole | Anastrozole | 14 | suppressed |
| Azithromycin | Azithromycin | 14 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 14 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 14 | suppressed |
| Levetiracetam Er | Levetiracetam | 14 | suppressed |
| Nifedipine Er | Nifedipine | 14 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 14 | suppressed |
| Acebutolol Hcl | Acebutolol Hcl | 13 | suppressed |
| Acyclovir | Acyclovir | 13 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 13 | suppressed |
| Calcitriol | Calcitriol | 13 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 13 | suppressed |
| Folic Acid | Folic Acid | 13 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 13 | suppressed |
| Ketoconazole | Ketoconazole | 13 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Nystop | Nystatin | 13 | suppressed |
| Spironolactone-Hctz | Spironolact/Hydrochlorothiazid | 13 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 13 | 11 |
| Sulfasalazine | Sulfasalazine | 13 | suppressed |
| Timolol Maleate | Timolol Maleate | 13 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 13 | suppressed |
| Amoxicillin | Amoxicillin | 12 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 12 | suppressed |
| Brilinta | Ticagrelor | 12 | suppressed |
| Colchicine | Colchicine | 12 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 12 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 12 | suppressed |
| Guanfacine Hcl | Guanfacine Hcl | 12 | suppressed |
| Insulin Lispro | Insulin Lispro | 12 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 12 | suppressed |
| Ranolazine Er | Ranolazine | 12 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 12 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 11 | 11 |
| Breo Ellipta | Fluticasone/Vilanterol | 11 | suppressed |
| Clorazepate Dipotassium | Clorazepate Dipotassium | 11 | suppressed |
| Dexamethasone | Dexamethasone | 11 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 11 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 11 | suppressed |
| Leflunomide | Leflunomide | 11 | suppressed |
| Levemir Flexpen | Insulin Detemir | 11 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 11 | suppressed |
| Modafinil | Modafinil | 11 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 11 | suppressed |
| Pentoxifylline | Pentoxifylline | 11 | suppressed |
| Phenytoin | Phenytoin | 11 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 11 | suppressed |
| Ramipril | Ramipril | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $568.76 · 5 records | Neurocrine BioSciences, Inc. | AUSTEDO XR, INGREZZA, NUPLAZID, SPRAVATO | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with Janssen Pharmaceuticals, Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error